283 related articles for article (PubMed ID: 2968374)
1. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
Koulu LM; Jansén CT
J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
[TBL] [Abstract][Full Text] [Related]
2. Skin photosensitizing and Langerhans' cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxypsoralen.
Koulu L; Jansén CT
Acta Derm Venereol; 1983; 63(2):137-41. PubMed ID: 6189328
[TBL] [Abstract][Full Text] [Related]
3. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
[TBL] [Abstract][Full Text] [Related]
4. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis.
Turjanmaa K; Salo H; Reunala T
Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716
[TBL] [Abstract][Full Text] [Related]
5. Trimethylpsoralen bath PUVA is a remittive treatment for psoriasis vulgaris. Evidence that epidermal immunocytes are direct therapeutic targets.
Coven TR; Murphy FP; Gilleaudeau P; Cardinale I; Krueger JG
Arch Dermatol; 1998 Oct; 134(10):1263-8. PubMed ID: 9801682
[TBL] [Abstract][Full Text] [Related]
6. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen.
Lowe NJ; Weingarten D; Bourget T; Moy LS
J Am Acad Dermatol; 1986 May; 14(5 Pt 1):754-60. PubMed ID: 3711379
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of methoxsalen and other psoralens.
de Wolff FA; Thomas TV
Clin Pharmacokinet; 1986; 11(1):62-75. PubMed ID: 3512141
[TBL] [Abstract][Full Text] [Related]
8. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
Nimkulrat P; Leenutaphong V; Sudtim S
J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
[TBL] [Abstract][Full Text] [Related]
9. Trimethylpsoralen bath plus ultraviolet A combined with oral retinoid (etretinate) in the treatment of severe psoriasis.
Väätäinen N; Hollmen A; Fräki JE
J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):52-5. PubMed ID: 3980803
[TBL] [Abstract][Full Text] [Related]
10. The effect of PUVA on langerhans cells in rat oral epithelium photosensitized with systemic methoxsalen or topical trioxsalen.
Kuusilehto A; Happonen RP; Peltola J; Lehtinen R; Jansén CT
Photodermatol Photoimmunol Photomed; 2000 Jun; 16(3):129-33. PubMed ID: 10885443
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
[TBL] [Abstract][Full Text] [Related]
12. Trioxsalen bath plus UVA effective and safe in the treatment of psoriasis.
Hannuksela M; Karvonen J
Br J Dermatol; 1978 Dec; 99(6):703-7. PubMed ID: 737133
[TBL] [Abstract][Full Text] [Related]
13. Effect of psoralens and ultraviolet radiation on murine dendritic epidermal cells.
Alcalay J; Bucana C; Kripke ML
J Invest Dermatol; 1989 May; 92(5):657-62. PubMed ID: 2565931
[TBL] [Abstract][Full Text] [Related]
14. The effect of methoxsalen dose on ultraviolet-A-induced erythema.
Ibbotson SH; Dawe RS; Farr PM
J Invest Dermatol; 2001 May; 116(5):813-5. PubMed ID: 11348476
[TBL] [Abstract][Full Text] [Related]
15. Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.
Legat FJ; Hofer A; Quehenberger F; Kahofer P; Kerl H; Wolf P
J Am Acad Dermatol; 2004 Nov; 51(5):746-54. PubMed ID: 15523353
[TBL] [Abstract][Full Text] [Related]
16. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA.
Hannuksela A; Pukkala E; Hannuksela M; Karvonen J
J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):685-9. PubMed ID: 8912561
[TBL] [Abstract][Full Text] [Related]
17. PUVA therapy for photosensitive psoriasis.
Ros AM; Wennersten G
Acta Derm Venereol; 1987; 67(6):501-5. PubMed ID: 2451375
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
Cox NH; Farr PM; Diffey BL
Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
20. PUVA therapy for polymorphous light eruptions: comparison of systemic methoxsalen and topical trioxsalen regimens and evaluation of local protective mechanisms.
Jansén CT; Karvonen J; Malmiharju T
Acta Derm Venereol; 1982; 62(4):317-20. PubMed ID: 6183864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
